Back to search
FDAFDA · Food and drugs·Recall number Z-1246-2014

Oxoid Vancomycin 30 mcg, each cartridge contains 50 susceptibility discs, CT0058B. The firm name on the label is Oxoid Ltd., Basingstoke, Hampshire, England. Used in the semi-quantitative agar diffusion test method for in-vitro susceptibility testing.

Published March 26, 2014 · Recall initiated: February 18, 2014

Summary

FDA records medical device Class II recall Z-1246-2014, published March 26, 2014 and initiated February 18, 2014. Recalling firm: Remel Inc; Status: Terminated; Reported quantity: 40/5/50-disc cartridge packages; Lot: Lot 1174497, exp. 2015/04. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Some of the discs may not be impregnated with the antibiotic.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Remel Inc
Distributor
Nationwide Distribution
Lot
Lot 1174497, exp. 2015/04
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Oxoid Vancomycin 30 mcg, each cartridge contains 50 susceptibility discs, CT0058B. The firm name on the label is Oxoid Ltd., Basingstoke, Hampshire, England. Used in the semi-quantitative agar diffusion test method for in-vitro susceptibility testing. recalled?

Yes. FDA published recall Z-1246-2014 on March 26, 2014. Reported hazard: Some of the discs may not be impregnated with the antibiotic.

What should I do if I have this product?

Voluntary: Firm initiated · Letter